Watson, David

Lecanemab in early Alzheimer's disease

van Dyck, C. H., Swanson, C. J., Aisen, P., Bateman, R. J., Chen, C., Gee, M., Kanekiyo, M., Li, D., Reyderman, L., Cohen, S., et al. (2023) · New England Journal of Medicine

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 5,678

Measurement of social-evaluative anxiety.

Watson, D., & Friend, R. (1969) · Journal of Consulting and Clinical Psychology

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychological Testing and Assessment

Cited by 3,467

Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial

Sims, J. R., Zimmer, J. A., Evans, C. D., Lu, M., Ardayfio, P., Sparks, J., Wessels, A. M., Shcherbinin, S., Wang, H., Monkul Nery, E. S., et al. (2023) · JAMA

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 2,932

Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium

Wilson, R., Sykes, D. A., Watson, D., Rutman, A., Taylor, G. W., & Cole, P. J. (1988) · Infection and Immunity

Bacterial biofilms and quorum sensingCystic Fibrosis Research Advances

Cited by 374

Two phase 3 trials of gantenerumab in early Alzheimer's disease

Bateman, R. J., Smith, J., Donohue, M. C., Delmar, P., Abbas, R., Salloway, S., Wojtowicz, J., Blennow, K., Bittner, T., Black, S. E., et al. (2023) · New England Journal of Medicine

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 314

Introduction to the Special Section: Toward a Dimensionally Based Taxonomy of Psychopathology.

Krueger, R. F., Watson, D., & Barlow, D. H. (2005) · Journal of Abnormal Psychology

Mental Health Research TopicsPersonality Disorders and Psychopathology

Cited by 263

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.

Burns, D. K., Alexander, R. C., Welsh-Bohmer, K. A., Culp, M., Chiang, C., O’Neil, J., Evans, R. M., Harrigan, P., Plassman, B. L., Burke, J. R., et al. (2021) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 130

STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction

Groom, K., McCowan, L., Mackay, L., Lee, A., Gardener, G., Unterscheider, J., Sekar, R., Dickinson, J., Muller, P., Reid, R., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology

Pregnancy and preeclampsia studiesPregnancy and Medication Impact

Cited by 88

Treatment of Acne Using a 3-Milligram Drospirenone/20-Microgram Ethinyl Estradiol Oral Contraceptive Administered in a 24/4 Regimen: A Randomized Controlled Trial

Maloney, J. M., Dietze, P., Watson, D., Niknian, M., Lee-Rugh, S., Sampson-Landers, C., & Korner, P. (2008) · Obstetrics & Gynecology

Acne and Rosacea Treatments and EffectsDermatologic Treatments and Research

Cited by 68

Rapid anxiety assessment in medical patients: Evidence for the validity of verbal anxiety ratings

Benotsch, E. G., Lutgendorf, S. K., Watson, D., Fick, L. J., & Lang, E. V. (2000) · Annals of Behavioral Medicine

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychometric Methodologies and Testing

Cited by 66

Introversion, neuroticism, rigidity, and dogmatism

Watson, D. L. (1967) · Journal of Consulting Psychology

Personality Traits and PsychologyPsychological Testing and Assessment

Cited by 10